Bioinformatics Services Market Worth USD 3.53 Billion : Growing Applications Of Bioinformatics In Various Industries
Seeking Alpha Analyst Since 2014
#Healthcare Consultant focusing on #TeleHealth #TeleMedicine #PatientPortals #CVIS #HCIT #MedicalRobots #Vaccines #MedicalDevices #WirelessHealth #Biotechnology
Summary
- What This Report Will Provide?
- Expected Revenue Growth.
- Major Growth Boosters.
What This Report Will Provide?
The bioinformatics services market, by application, is segmented into genomics, chemoinformatics & drug design, proteomics, transcriptomics, metabolomics, and other applications. The significant growth of the segment is attributed to the rising demand for more efficient data management facilities and the increasing number of research studies for the treatment of cancer using transcriptomics.
Expected Revenue Growth:
The global bioinformatics services market is expected to reach USD 3.53 billion by 2023 from USD 1.70 billion in 2018, at a CAGR of 15.7% during the forecast period.
Major Growth Boosters:
Growth in the global bioinformatics services market is mainly driven by the growing applications of bioinformatics in various industries, increasing public-private sector funding for bioinformatics services, and the shortage of skilled bioinformatics professionals leading to increased outsourcing of bioinformatics projects. The reducing cost of sequencing and growing volume of data generated during sequencing, growing focus on outsourcing for the management of large volumes of data, and the emerging markets are also expected to present growth opportunities for players in the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=75889439
Study Objectives:
- In 2017, QIAGEN and Centogene (Germany) collaborated to integrate Centogene’s CentoMD rare disease variant database with Qiagen Clinical Insight bioinformatics solution
- In 2017, NeoGenomics established its first European laboratory in Rolle, Switzerland to expand its geographical presence and increase its sales in Europe.
- In 2017, QIAGEN acquired OmicSoft Corporation (US) to enhance its multi-omics data analysis bioinformatics services offerings
- In 2016, Eurofins partnered with Institute of Genomics and Integrative Biology (IGIB, India) to launch their MitoSure-Human mitochondrial DNA sequencing and analysis pipeline to support research and genetic screening. The service includes automated bioinformatics analysis using IGIB proprietary Mit-O-Matic pipelineIn 2017, ConvaTec launched its Natura Convex Accordion Flange
- In 2015, PerkinElmer launched the PerkinElmer Signals Translational—a cloud-based data analysis platform
Key Questions Addressed in The Report:
- What are the growth opportunities related to bioinformatics service market across major regions in the future?
- Emerging countries have immense opportunities for the growth and adoption of bioinformatics service. Will this scenario continue in the next five years?
- What are the various bioinformatics service segments and their market share in the overall market?
- What are the new trends and advancements in the bioinformatics service market?
Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=75889439
Growing applications of bioinformatics in various industries
In comparison with other conventional methods, bioinformatics services provide a wide range of advantages in terms of cost and time efficiency. Owing to these advantages, the applications of bioinformatics services are increasing in a number of fields such as toxicology, survival analysis, drug discovery and development, clinical diagnostics, disease prediction, and personalized medicine.
Regional Growth Analysis:
This report covers the bioinformatics services market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America accounted for the largest share of the global bioinformatics services market in 2017, followed by Europe. The large share of the North American region is mainly attributed to the presence of leading bioinformatics service providers in the region, decreasing cost of sequencing, increasing number of genomic research activities in the region, high incidence of target diseases (such as cancer and genetic diseases), and favorable funding scenario for bioinformatics-based research.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.